参考文献/References:
[1] 李 赟.系统性红斑狼疮患者血清补体C5a和红细胞沉降率检测及临床意义[J].陕西医学杂志,2020,49(1):52-55.
[2] 韦佩祺,苏梓健,梁 芳,等.microRNA在系统性红斑狼疮中的作用机制研究进展[J].陕西医学杂志,2023,52(2):238-封3.
[3] Moore E,Huang MW,Putterman C.Advances in the diagnosis,pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus[J].Curr Opin Rheumatol,2020,32(2):152-158.
[4] 杜 明,陶 李,王昱斌,等.S100A8/A9和S100A12在系统性红斑狼疮患者血清中的表达水平及临床意义[J].免疫学杂志,2019,35(7):599-606.
[5] Guo D,Zhu Z,Xu T,et al.Plasma S100A8/A9 concentrations and clinical outcomes of ischemic stroke in 2 independent multicenter cohorts[J].Clin Chem,2020,66(5):706-717.
[6] Aamodt WW,Waligorska T,Shen J,et al.Neurofilament light chain as a biomarker for cognitive decline in parkinson disease[J].Mov Disord,2021,36(12):2945-2950.
[7] 中华医学会风湿病学分会.系统性红斑狼疮诊断及治疗指南[J].中华风湿病学杂志,2010,14(5):342-346.
[8] Aringer M,Costenbader K,Daikh D,et al.2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J].Ann Rheum Dis,2019,78(9):1151-1159.
[9] Gladman DD,Ibanez D,Urowitz MB.Systemic lupus erythematosus disease activity index 2000[J].J Rheumatol,2002,29(2):288-291.
[10] 赵亚峰,边 静,李娜梅,等.狼疮性肾炎患者中医证型与临床病理分析[J].陕西中医,2019,40(11):1555-1558.
[11] 杨 帆,沈俊逸,林彤彤,等.清瘟败毒饮联合糖皮质激素、环磷酰胺治疗系统性红斑狼疮气营热盛证临床研究[J].陕西中医,2020,41(9):1197-1199,1204.
[12] Sreejit G,Abdel-Latif A,Athmanathan B,et al.Neutrophil-derived S100A8/A9 amplify granulopoiesis after myocardial infarction[J].Circulation,2020,141(13):1080-1094.
[13] De-Moel EC,Rech J,Mahler M,et al.Circulating calprotectin(S100A8/A9)is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs[J].Arthritis Res Ther,2019,21(1):268.
[14] Davies JC,Midgley A,Carlsson E,et al.Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment[J].RMD Open,2020,6(2):e001257.
[15] Hagmeyer S,Romão MA,Cristóvão JS,et al.Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer's disease model mice[J].Front Neurosci,2019,13:640.
[16] Wang Z,Zheng G,Li G,et al.Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation[J].J Cell Mol Med,2020,24(23):13703-13714.
[17] Mollenhauer B,Dakna M,Kruse N,et al.Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression[J].Mov Disord,2020,35(11):1999-2008.
[18] Benkert P,Meier S,Schaedelin S,et al.Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis:A retrospective modelling and validation study[J].Lancet Neurol,2022,21(3):246-257.
[19] Karantali E,Kazis D,Chatzikonstantinou S,et al.The role of neurofilament light chain in frontotemporal dementia:A meta-analysis[J].Aging Clin Exp Res,2021,33(4):869-881.
[20] Yuan A,Rao MV,Veeranna A,et al.Neurofilaments and neurofilament proteins in health and disease[J].Cold Spring Harb Perspect Biol,2017,9(4):a018309.